Business Context and Reporting Period
Nature's Sunshine Products, Inc. (NATR) is a global manufacturer and marketer of herbal and nutritional supplements sold through a network of independent consultants. This Form 10-Q covers the quarterly period ended June 30, 2026. The Company operates four reportable segments: Asia, Europe, North America, and Latin America and Other.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2026 |
Six Months Ended June 30, 2026 |
|---|---|---|
| Net Sales | $116.99 million | $239.88 million |
| Gross Profit | $86.17 million (73.7% margin) | $176.15 million (73.4% margin) |
| Operating Income | $5.48 million (4.7% margin) | $15.03 million (6.3% margin) |
| Net Income | $3.54 million | $8.66 million |
| Diluted EPS | $0.19 | $0.48 |
| Cash and Equivalents | $82.50 million (as of June 30, 2026) | |
| Working Capital | ||
| Debt | No outstanding balance on revolving credit facility |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 1.9% ($2.2M) for the quarter and 5.2% ($11.9M) for the six months compared to 2025. Excluding foreign currency impacts, sales grew 3.8% (quarter) and 5.3% (six months).
- Profitability: Operating income rose 28.2% for the quarter and 43.8% for the six months, driven by improved gross margins (down from 28.3% to 26.3% cost of sales ratio) and cost savings initiatives.
- Net Income Decline: Despite higher operating income, net income decreased 35.9% for the quarter and 16.8% for the six months. This was primarily due to a significant swing in foreign exchange results, which shifted from a $3.0M gain in Q2 2025 to a $0.2M loss in Q2 2026.
- Segment Performance:
- Asia: Sales grew 0.6% (USD) / 5.3% (local currency). Japan saw strong growth (+38.3%), while Taiwan declined (-17.9%).
- Europe: Sales increased 4.4% (USD) / 3.7% (local currency).
- North America: Sales increased 2.8% (USD), driven by improved digital consumer acquisition in the U.S.
Outlook, Risks, and Unusual Items
- Foreign Exchange: The Company faces significant exposure to currency fluctuations, particularly in Asian markets, which negatively impacted reported sales and earnings in the current period.
- Regulatory Investigations: The Company voluntarily disclosed potential trade control violations to the U.S. Department of Commerce (BIS) and the Office of Foreign Assets Control (OFAC). The BIS matter was closed without action; the OFAC matter remains pending. Management estimates potential fines would not be material.
- Geopolitical Risks: Ongoing conflict in Eastern Europe continues to impact operations, though sales in the region increased year-over-year.
- Tariffs: Management expects tariffs may adversely affect costs in the remainder of 2026, though no material impact was seen in the first half.
- Capital Allocation: The Company repurchased 113,000 shares for $2.6 million in the first half of 2026. $14.8 million remains available under the repurchase program.
Investor Verification Checklist
- FX Sensitivity: Verify the magnitude of foreign exchange losses and their impact on future earnings guidance, given the volatility in Asian currencies.
- OFAC Resolution: Monitor the status of the pending OFAC investigation regarding trade control violations for potential fines or operational restrictions.
- China Operations: Review the performance of the China market following the 100% acquisition of joint ventures in late 2025, noting the Q2 sales decline in local currency.
- Cash Flow: Note that operating cash flow turned negative ($1.0M outflow) for the six months ended June 30, 2026, compared to a $6.9M inflow in the prior year, driven by working capital changes.
- Share Repurchases: Confirm the pace of share buybacks relative to the remaining $14.8M authorization and cash generation capabilities.